BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15574559)

  • 1. Blood product use during orthotopic liver transplantation.
    Shan WL; Barkun J; Metrakos P; Tchervenkov J; Backman SB
    Can J Anaesth; 2004 Dec; 51(10):1045-6. PubMed ID: 15574559
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation.
    Grosse H; Lobbes W; Frambach M; Ringe B; Barthels M
    Semin Thromb Hemost; 1993; 19(3):302-5. PubMed ID: 7689757
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aprotinin in orthotopic liver transplantation].
    García Huete L; Sabaté Pes A
    Med Clin (Barc); 1997 Mar; 108(11):439. PubMed ID: 9213647
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aprotinin in the control of surgical hemorrhage].
    Rocha E; Antonio Páramo J; Hermida J
    Med Clin (Barc); 1996 Mar; 106(8):307-16. PubMed ID: 8667690
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
    Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
    Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of two different dosages of aprotonin on perioperative blood loss during liver transplantation.
    Ickx B; Pradier O; DeGroote F; Hendrice C; Toungouz M; Vandestadt J; Gelin M; Capel P
    Semin Thromb Hemost; 1993; 19(3):300-1. PubMed ID: 7689756
    [No Abstract]   [Full Text] [Related]  

  • 7. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
    Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does aprotinin really reduce blood loss in orthotopic liver transplantation?
    Groh J; Welte M; Azad SC; Anthuber M; Haller M; Kratzer MA
    Semin Thromb Hemost; 1993; 19(3):306-8. PubMed ID: 7689758
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effects of aprotinin. Blood loss and coagulation parameters in orthotopic liver transplantation: A clinical-experimental, prospective and randomized double-blind study].
    Kratzer MA; Azad SC; Groh J; Welte M; Haller M; Pratschke E
    Anaesthesist; 1997 Apr; 46(4):294-302. PubMed ID: 9229983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduction of blood loss in orthotopic liver transplantation with the use of aprotinin].
    Légaré G; Roy A; Dagenais M; Lapointe R; Marleau D; Thuot C
    Ann Chir; 1996; 50(8):601-5. PubMed ID: 9035431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aprotinin -- an allogeneic transfusion sparing drug].
    Haas S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):38-40. PubMed ID: 12522728
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute normovolemic hemodilution together with aprotinin applied as a scheme of blood saving in cardiac surgery].
    Pawlak S; Czech B; Kucewicz E; Szapiel G; Juszczyk G; Frank M
    Przegl Lek; 2002; 59(10):796-9. PubMed ID: 12632915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss.
    Pereboom IT; de Boer MT; Porte RJ; Molenaar IQ
    Dig Surg; 2007; 24(4):282-7. PubMed ID: 17657153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD score and blood product requirements during liver transplantation: no link.
    Massicotte L; Beaulieu D; Roy JD; Marleau D; Vandenbroucke F; Dagenais M; Lapointe R; Roy A
    Transplantation; 2009 Jun; 87(11):1689-94. PubMed ID: 19502961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reduction of the need for blood derivatives in liver transplantation using aprotinin].
    Monedero P; Páramo JA; Carrascosa F; Herrero JI; Hidalgo F; Iribarren MJ; García-Pedrajas F
    Rev Esp Anestesiol Reanim; 1995 Mar; 42(3):82-6. PubMed ID: 7539932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Goal-directed" transfusion management leads to distinct reduction of fluid requirement in liver transplantation.
    Gerlach H; Rossaint R; Bechstein WO; Blumhardt G; Neuhaus P; Falke K
    Semin Thromb Hemost; 1993; 19(3):282-5. PubMed ID: 7689753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin's effect on blood product transfusion in off-pump bilateral lung transplantation.
    Balsara KR; Morozowich ST; Lin SS; Davis RD; Phillips-Bute BG; Hartwig M; Appel JZ; Welsby IJ
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):45-8. PubMed ID: 18669527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perioperative blood loss--the role of the anesthetist].
    Booke M; Mertes N; Wüllenweber J; Van Aken H
    Dtsch Med Wochenschr; 1998 Apr; 123(18):569-72. PubMed ID: 9615697
    [No Abstract]   [Full Text] [Related]  

  • 19. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
    Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
    Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin during liver transplantation.
    Lentschener C; Benhamou D
    Br J Anaesth; 1996 Jun; 76(6):882. PubMed ID: 8679372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.